Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.

[1]  J. Reiber,et al.  Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. , 1987, Atherosclerosis.

[2]  K. Ichinose,et al.  Multiple regression analysis of sixteen risk factors including serum apolipoproteins in angiographically documented coronary artery disease. , 1987, Japanese circulation journal.

[3]  G. Utermann,et al.  Apolipoprotein E polymorphism in health and disease. , 1987, American heart journal.

[4]  R. Hoffmann,et al.  Risk factors among patients undergoing repeat aorta-coronary bypass procedures. , 1987, The Journal of thoracic and cardiovascular surgery.

[5]  J. Barboriak,et al.  Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. , 1986, Arteriosclerosis.

[6]  R. Norum,et al.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. , 1986, The Journal of clinical investigation.

[7]  R. Havel,et al.  Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. , 1985, Journal of lipid research.

[8]  P. Nestel,et al.  Lipoprotein predictors of the severity of coronary artery disease in men and women. , 1985, Circulation.

[9]  W. Castelli,et al.  Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.

[10]  A. Morineau,et al.  Multivariate descriptive statistical analysis , 1984 .

[11]  R. Glynn,et al.  Changes in Cholesterol and Triglyceride as Predictors of Ischemic Heart Disease in Men , 1982, Circulation.

[12]  B. Kristensen.  Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins. , 1981, British medical journal.

[13]  O. Andersson,et al.  BETA-BLOCKERS OR DIURETICS IN HYPERTENSION? A SIX YEAR FOLLOW-UP OF BLOOD PRESSURE AND METABOLIC SIDE EFFECTS , 1981, The Lancet.

[14]  W. Meyers,et al.  Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. , 1980, The Journal of clinical investigation.

[15]  G. Kostner,et al.  Determination of high-density lipoproteins: screening methods compared. , 1979, Clinical chemistry.

[16]  P. Alaupovic,et al.  Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms , 1974, FEBS letters.

[17]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[18]  D. Cox,et al.  The analysis of binary data , 1971 .

[19]  R. Havel,et al.  Role of Specific Glycopeptides of Human Serum Lipoproteins in the Activation of Lipoprotein Lipase , 1970, Circulation research.

[20]  P. Trinder.  Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .

[21]  G. Rolinson,et al.  Microbiological Studies on a New Broad-spectrum Penicillin, “Penbritin”* , 1961, British medical journal.